Endodermal Sinus Tumor: Clinical Trials

5 trials for Endodermal Sinus Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 5
Phase 21Completed 1

Follow Endodermal Sinus Tumor: new trials by email Literature Review of Endodermal Sinus Tumor trials Research Report on Endodermal Sinus Tumor

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer
ipilimumab, therapeutic allogeneic lymphocytes - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
Phase 1CompletedNational Cancer Institute (NCI)212003-04-012013-03-27
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon
beclomethasone dipropionate - Breast Cancer, Chronic Myeloproliferative Disorders
Phase 1 / Phase 2CompletedFred Hutchinson Cancer Center2000-07-012010-04-02
Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors
recombinant interleukin-12 - Breast Cancer, Chronic Myeloproliferative Disorders
Phase 1CompletedIndiana University1997-10-012014-09-10
MEN-10755 in Treating Patients With Solid Tumors
sabarubicin - Testicular Germ Cell Tumor, Unspecified Adult Solid Tumor, Protocol Specific
Phase 1CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC301997-06-012012-07-11
Biological Therapy in Treating Patients With Metastatic Cancer
CEA RNA-pulsed DC cancer vaccine - Breast Cancer, Colorectal Cancer
Phase 1CompletedDuke University241997-02-012013-02-22

Narrower conditions

Breast Neoplasms (4)  ·  Carcinoma, Ovarian Epithelial (4)  ·  Testicular Germ Cell Tumor (4)  ·  Testicular Neoplasms (4)  ·  Burkitt Lymphoma (3)  ·  Carcinoma, Embryonal (3)  ·  Hodgkin Disease (3)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (3)  ·  Leukemia, Myeloid, Acute (3)  ·  Lymphoma, Follicular (3)  ·  Lymphoma, Large B-Cell, Diffuse (3)  ·  Lymphoma, Large-Cell, Immunoblastic (3)  ·  Lymphoma, Mantle-Cell (3)  ·  Lymphoma, Non-Hodgkin (3)

Broader conditions

Mesonephroma (5)  ·  Neoplasms by Histologic Type (5)  ·  Neoplasms, Germ Cell and Embryonal (5)  ·  Adnexal Diseases (4)  ·  Breast Diseases (4)  ·  Carcinoma (4)  ·  Endocrine Gland Neoplasms (4)  ·  Endocrine System Diseases (4)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Genital Diseases (4)  ·  Genital Diseases, Female (4)  ·  Genital Diseases, Male (4)  ·  Genital Neoplasms, Female (4)  ·  Genital Neoplasms, Male (4)

Interventions

Beclomethasone (1)  ·  CTLA-4 Antigen (1)  ·  Interleukin-12 Subunit p35 (1)  ·  Ipilimumab (1)  ·  sabarubicin (1)

Sponsors

Duke University (1)  ·  European Organisation for Research and Treatment of Cancer - EORTC (1)  ·  Fred Hutchinson Cancer Center (1)  ·  Indiana University (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (4)  ·  Austria (1)  ·  Belgium (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

David Hockenbery, MD (1)  ·  Ewa Carrier (1)  ·  Herbert K. Lyerly, MD (1)  ·  Michael J. Robertson, MD (1)

Results publications

PMID 18974373

NIH funding

R01CA093891 (1)